# Articaine Efficacy and Safety for 3 Years Old Children

> **NCT05839548** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Qassim Health Cluster** · enrollment: 200 (estimated)

## Conditions studied

- Dental Caries in Children
- Dental Diseases
- Pulp Disease, Dental
- Behavior, Child

## Interventions

- **DRUG:** Mepivacaine 2% with epinephrine 1:100,000
- **DRUG:** Articaine (4%) with epinephrine 1:100,000

## Key facts

- **NCT ID:** NCT05839548
- **Lead sponsor:** Qassim Health Cluster
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-07-01
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839548, "Articaine Efficacy and Safety for 3 Years Old Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05839548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*